| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.2 | 0.2 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |